Clinical trials
Phase 4 Emphysema trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 4 |
| 2010 | 1 |
| 2011 | 5 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2017 | 7 |
| 2018 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Unknown status | 6 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Zurich | 9 |
| CSL Behring | 3 |
| Eric A. Hoffman | 3 |
| Johns Hopkins University | 3 |
| Sumitomo Pharma America, Inc. | 3 |
| Hospitales Universitarios Virgen del Rocío | 2 |
| LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology | 2 |
| University of California, Los Angeles | 2 |
| Hospital Son Llatzer | 1 |
| JHSPH Center for Clinical Trials | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emphysema | 36 |
| Pulmonary Disease, Chronic Obstructive | 30 |
| Bronchitis, Chronic | 10 |
| Bronchitis | 7 |
| alpha 1-Antitrypsin Deficiency | 3 |
| Lung Diseases | 2 |
| Lung Diseases, Obstructive | 2 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Disease | 1 |
| Dyspnea | 1 |
Trials
Showing 51 to 36 of 36. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.